Regulation

TEVA Form 144 Filed on June 18 for Regulatory Compliance

Published on 6/19/2026

#TEVA#SEC#Regulation
TEVA Form 144 Filed on June 18 for Regulatory Compliance

AI Summary

Summarized by AI from the source below

On June 18, 2023, Teva Pharmaceutical Industries Ltd (TEVA) filed Form 144, which allows for the sale of restricted securities. This filing indicates potential stock transactions by insiders as required by SEC regulations. Such filings can impact market perception on TEVA's liquidity and shareholder structure. Monitoring these filings is important for investors seeking insights into the company's internal equity movements.

Share:
Source: Read original article (opens in new tab)

Get the free market brief

Top stories and analysis, summarized. No spam, unsubscribe anytime.

Related News

Karmelo Anthony denied new trial request in stabbing case
Regulation

Karmelo Anthony denied new trial request in stabbing case

Aug 22

Court Reduces Alex Jones Judgment by $50M in Sandy Hook Case
Regulation

Court Reduces Alex Jones Judgment by $50M in Sandy Hook Case

Aug 22

Paramount (PARA) and California A.G. to Discuss Antitrust Settlement
M&A

Paramount (PARA) and California A.G. to Discuss Antitrust Settlement

Aug 22

TikTok (TIKTOK) $400 Million Settlement Over Children's Privacy
Regulation

TikTok (TIKTOK) $400 Million Settlement Over Children's Privacy

Aug 22